Biology of the Endoplasmic Reticulum
暫譯: 內質網的生物學

Lorenzo Galluzzi (born 1980) is currently Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College (New York, USA), and Honorary Associate Professor at the Faculty of Medicine of the Paris Descartes University (Paris, France).

Prior to joining Weill Cornell Medical College (2017), Lorenzo Galluzzi was a Junior Scientist of the Research Team "Apoptosis, Cancer and Immunity" at the Cordeliers Research Center (Paris, France; 2012-2016). Lorenzo Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center (Villejuif, France; 2009-2011), after receiving his PhD from the Paris Sud University (Le Kremlin-Bicetre, France; 2005-2008). He is also Associate Director of the European Academy for Tumor Immunology (EATI), and Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP).

Lorenzo Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. Lorenzo Galluzzi has published more than 350 scientific articles in international peer-reviewed journals. According to a survey published by Lab Times, he is currently the 6th and the youngest of the 30 most-cited European cell biologists (relative to the period 2007-2013).

Lorenzo Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded in 2013). In addition, Lorenzo Galluzzi currently serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease.

洛倫佐·加盧齊（Lorenzo Galluzzi，1980年出生）目前是美國紐約威爾康奈爾醫學院（Weill Cornell Medical College）放射腫瘤學系的細胞生物學助理教授，並且是法國巴黎笛卡爾大學（Paris Descartes University）醫學院的名譽副教授。

在加入威爾康奈爾醫學院之前（2017年），洛倫佐·加盧齊曾擔任法國巴黎科爾德利耶研究中心（Cordeliers Research Center）「細胞凋亡、癌症與免疫」研究團隊的初級科學家（2012-2016年）。他在法國維爾喬伊夫的古斯塔夫·魯西癌症中心（Gustave Roussy Cancer Center）完成了博士後訓練（2009-2011年），並於法國巴黎南大學（Paris Sud University）獲得博士學位（2005-2008年）。他同時也是歐洲腫瘤免疫學院（European Academy for Tumor Immunology，EATI）的副主任，以及歐洲綜合細胞病理研究所（European Research Institute for Integrated Cellular Pathology，ERI-ICP）的創始成員。

洛倫佐·加盧齊因其在細胞死亡、自噬、腫瘤代謝和腫瘤免疫學領域的重大實驗和概念貢獻而聞名。特別是，他對癌細胞中的適應性壓力反應與臨床相關的腫瘤靶向免疫反應在化療和放療背景下的聯繫提供了深刻的見解。洛倫佐·加盧齊在國際同行評審期刊上發表了超過350篇科學文章。根據《Lab Times》發表的調查，他目前是2007年至2013年期間引用次數最多的30位歐洲細胞生物學家中的第六位，也是最年輕的一位。

洛倫佐·加盧齊目前擔任三本期刊的主編：他於2011年共同創辦的《腫瘤免疫學》（OncoImmunology）、《國際細胞與分子生物學評論》（International Review of Cell and Molecular Biology）以及他於2013年共同創辦的《分子與細胞腫瘤學》（Molecular and Cellular Oncology）。此外，洛倫佐·加盧齊目前還擔任《微生物細胞》（Microbial Cell）和《細胞壓力》（Cell Stress）的創始編輯，以及《細胞死亡與疾病》（Cell Death and Disease）的副編輯。